Annual Long Term Debt
$71.74 M
+$31.91 M+80.13%
31 December 2023
Summary:
Galectin Therapeutics annual long term debt is currently $71.74 million, with the most recent change of +$31.91 million (+80.13%) on 31 December 2023. GALT annual long term debt is now at all-time high.GALT Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Debt
$94.04 M
+$615.00 K+0.66%
30 September 2024
Summary:
Galectin Therapeutics quarterly long term debt is currently $94.04 million, with the most recent change of +$615.00 thousand (+0.66%) on 30 September 2024. Over the past year, it has increased by +$32.86 million (+53.72%). GALT quarterly long term debt is now at all-time high.GALT Quarterly Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GALT Long Term Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +80.1% | +53.7% |
| 3 y3 years | - | +387.3% |
| 5 y5 years | - | - |
GALT Long Term Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +147.0% | at high | +387.3% |
| 5 y | 5 years | at high | +147.0% | at high | >+9999.0% |
| alltime | all time | at high | +147.0% | at high | >+9999.0% |
Galectin Therapeutics Long Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $94.04 M(+0.7%) |
| June 2024 | - | $93.42 M(+13.3%) |
| Mar 2024 | - | $82.47 M(+15.0%) |
| Dec 2023 | $71.74 M(+80.1%) | $71.74 M(+17.3%) |
| Sept 2023 | - | $61.17 M(+1.3%) |
| June 2023 | - | $60.36 M(+20.7%) |
| Mar 2023 | - | $50.00 M(+25.5%) |
| Dec 2022 | $39.83 M(+37.1%) | $39.83 M(+33.6%) |
| Sept 2022 | - | $29.81 M(+0.7%) |
| June 2022 | - | $29.59 M(+1.1%) |
| Mar 2022 | - | $29.27 M(+0.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2021 | $29.05 M | $29.05 M(+50.5%) |
| Sept 2021 | - | $19.30 M(+100.1%) |
| June 2021 | - | $9.64 M(>+9900.0%) |
| Sept 2020 | - | $19.00 K(-38.7%) |
| June 2020 | - | $31.00 K(-24.4%) |
| Mar 2020 | - | $41.00 K(-98.2%) |
| Sept 2006 | - | $2.28 M(-56.7%) |
| June 2006 | - | $5.26 M(-47.0%) |
| Mar 2006 | - | $9.92 M(+4985.1%) |
| Sept 2001 | - | $195.00 K(-85.1%) |
| June 2001 | - | $1.31 M |
FAQ
- What is Galectin Therapeutics annual long term debt?
- What is the all time high annual long term debt for Galectin Therapeutics?
- What is Galectin Therapeutics annual long term debt year-on-year change?
- What is Galectin Therapeutics quarterly long term debt?
- What is the all time high quarterly long term debt for Galectin Therapeutics?
- What is Galectin Therapeutics quarterly long term debt year-on-year change?
What is Galectin Therapeutics annual long term debt?
The current annual long term debt of GALT is $71.74 M
What is the all time high annual long term debt for Galectin Therapeutics?
Galectin Therapeutics all-time high annual long term debt is $71.74 M
What is Galectin Therapeutics annual long term debt year-on-year change?
Over the past year, GALT annual long term debt has changed by +$31.91 M (+80.13%)
What is Galectin Therapeutics quarterly long term debt?
The current quarterly long term debt of GALT is $94.04 M
What is the all time high quarterly long term debt for Galectin Therapeutics?
Galectin Therapeutics all-time high quarterly long term debt is $94.04 M
What is Galectin Therapeutics quarterly long term debt year-on-year change?
Over the past year, GALT quarterly long term debt has changed by +$32.86 M (+53.72%)